Previous close | 6.20 |
Open | 6.35 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 46.00 |
Expiry date | 2024-10-18 |
Day's range | 6.20 - 6.35 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or....
The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...